Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Advances in Biologics and CGT

Advances in Biologics and CGT

September 28, 5 - 7:30pm EDT | Cambridge, MA

We are excited to share that we will be joining the Advances in Biologics and CGT Networking Reception hosted by Catalent. This event will bring C-suite executives, and venture capital investors for an invite only Happy Hour at Cambridge’s Biotech hub.

Sean Forestell, Director, CMC Operations of Alira Health will be joining a discussion “Unveiling Biologic and Cell & Gene Therapy Market Trends” among other industry experts, uncovering the latest trends and advancements in the Biologics and Cell & Gene Therapy markets.

If you would like to take a deeper dive into the rapidly growing global Biologics and Advanced Therapies market, download our latest 2023 Biologics and Advanced Therapies Contract Manufacturing Report.

 

Our Speaker
Events
Category:
Biologics CMC
Published on:
September 27, 2023
Sean Forestell

Sean Forestell

 Director, CMC Operations Sean Forestell, Ph.D. is an expert in biologics process development and manufacturing with over 30 years of experience in the biotech industry, including senior leadership roles at BioMarin, Genentech, and Novartis. Dr. Forestell’s broad experience includes viral vectors used in cell and gene therapy, monoclonal antibodies, and enzymes to treat ultra rare diseases that are produced using continuous manufacturing technologies. He has been involved in the successful technology transfer of 12 early-stage clinical products and four successful process performance qualifications (PPQs), and has supported the manufacture of eight different commercial products. Dr. Forestell earned a B.Sc. in biological engineering at the University of Guelph and a Ph.D. in chemical engineering from the University of Calgary. He has co-authored 19 articles in peer-reviewed journals and is an inventor on two issued patents.

Related news

Reports December 12, 2024
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
Advanced Therapies Biologics CDMO
Articles November 12, 2024
Global Biosimilars Landscape in 2024: Trends, Challenges, and Opportunities
The introduction of biosimilars marks a significant evolution in healthcare, offering comparable therapeutic benefits at lower costs.
Biologics Biosimilars Drug Development
Case Studies October 31, 2024
Family Office Optimizes Biosimilar Investments Through Strategic Capital Market Transaction
A client reached out to appropriately value two biosimilar assets, facilitate discussions with its management, and coordinate the capital market transaction as an asset-contribution in kind.
Biologics Transaction Advisory
News October 29, 2024
Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market
The report provides a comprehensive analysis of global biosimilar trends, with a focus on competitive dynamics in the US and Europe.
Biologics Biosimilars Pharma
Reports October 23, 2024
2024 Global Biosimilars Report
Download for an assessment of trends in the global biosimilar market, with an emphasis on market and competitive dynamics in the US and Europe.
Biologics Biosimilars Drug Development
Articles October 17, 2024
Navigating Growth: Insights into the Expanding Global Biosimilars Market 2024
To learn more about the drivers and restraints in biosimilars, and predictions for the next decade, we spoke to expert Christian Hughes.
Biologics
Articles October 16, 2024
Biologics and Advanced Therapies Contract Manufacturing Industry: Current Trends, Challenges, and Opportunities
Summary of the 2024 Biologics and Advanced Therapies Contract Manufacturing Report including industry performance and outsourcing trends.
Advanced Therapies Biologics CDMO
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.